Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    acp-103-015
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Condition: Parkinson's Disease Psychosis
Intervention: Drug: pimavanserin tartrate (ACP-103)

Study has passed its completion date and status has not been verified in more than two years.